HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glenn J Jaffe Selected Research

Open-Angle Glaucoma (Glaucoma, Open Angle)

12/2015Improved Surgical Success of Combined Glaucoma Tube Shunt and Retisert(®) Implantation in Uveitic Eyes: A Retrospective Study.
9/2003Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Glenn J Jaffe Research Topics

Disease

59Macular Degeneration (Age-Related Maculopathy)
03/2024 - 01/2005
31Macular Edema
12/2023 - 09/2003
25Uveitis
01/2021 - 07/2002
20Inflammation (Inflammations)
03/2024 - 06/2002
13Panuveitis
09/2023 - 08/2005
12Geographic Atrophy
10/2023 - 04/2011
12Atrophy
01/2022 - 09/2011
11Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 01/2012
10Retinal Perforations
11/2021 - 01/2004
10Posterior Uveitis
01/2021 - 07/2005
10Cicatrix (Scar)
01/2021 - 03/2014
9Cataract (Cataracts)
02/2023 - 07/2005
9Glaucoma
12/2017 - 09/2003
7Choroidal Neovascularization
07/2017 - 01/2004
6Proliferative Vitreoretinopathy
08/2011 - 03/2003
5Disease Progression
10/2023 - 02/2013
4Retinal Vasculitis
01/2024 - 01/2021
4Endophthalmitis (Ophthalmia)
09/2023 - 02/2009
4Telangiectasis (Telangiectasia)
01/2022 - 01/2017
4Intermediate Uveitis (Chronic Cyclitis)
01/2021 - 10/2008
4Neoplasms (Cancer)
10/2018 - 06/2002
3Polypoidal Choroidal Vasculopathy
09/2023 - 12/2019
3Edema (Dropsy)
01/2019 - 06/2003
3Retinal Detachment (Retinal Detachments)
01/2017 - 11/2002
3Epiretinal Membrane (Epiretinal Membranes)
01/2017 - 02/2003
3Retinal Vein Occlusion
01/2012 - 09/2003
2Lymphoma (Lymphomas)
04/2023 - 05/2005
2Retinitis Pigmentosa (Pigmentary Retinopathy)
12/2022 - 08/2013
2Retinal Degeneration
12/2022 - 01/2019
2Retinal Diseases
01/2020 - 08/2011
2Hypersensitivity (Allergy)
03/2017 - 07/2002
2Open-Angle Glaucoma (Glaucoma, Open Angle)
12/2015 - 09/2003
2Cysts
10/2015 - 01/2004
2Infections
03/2003 - 06/2002
1Lacrimal Duct Obstruction
09/2023
1Scleritis (Episcleritis)
09/2023
1Usher Syndromes (Usher Syndrome)
12/2022
1Ischemia
09/2021
1Optic Nerve Diseases (Optic Neuropathy)
09/2021
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
01/2021

Drug/Important Bio-Agent (IBA)

49Retinaldehyde (Retinal)IBA
01/2024 - 06/2003
25Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2024 - 02/2013
20Fluocinolone Acetonide (Capex)FDA LinkGeneric
09/2023 - 07/2005
18Ranibizumab (Lucentis)FDA Link
01/2022 - 05/2011
15Fluorescein (Funduscein)FDA LinkGeneric
09/2021 - 02/2013
14afliberceptIBA
08/2023 - 01/2014
13Bevacizumab (Avastin)FDA Link
01/2022 - 05/2011
8brolucizumabIBA
01/2024 - 01/2017
8Adrenal Cortex Hormones (Corticosteroids)IBA
09/2023 - 10/2008
7Retinal Pigments (Pigments, Visual)IBA
01/2020 - 03/2003
6Adalimumab (Humira)FDA Link
04/2023 - 09/2016
6microplasminIBA
01/2019 - 09/2012
5salicylhydroxamic acid (SHAM)IBA
10/2023 - 08/2013
5Biomarkers (Surrogate Marker)IBA
09/2023 - 01/2016
4SteroidsIBA
01/2021 - 12/2016
4Proteins (Proteins, Gene)FDA Link
01/2020 - 07/2002
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
09/2023 - 07/2017
3Platelet-Derived Growth FactorIBA
05/2020 - 01/2016
3Ciliary Neurotrophic Factor (CNTF)IBA
01/2019 - 04/2011
3fluocinoloneIBA
04/2008 - 07/2005
22,4- diamino- 5- cyclohexyl- 6- methylpyrimidineIBA
02/2023 - 10/2015
2AntibodiesIBA
01/2022 - 10/2018
2N-acetyltryptophanamide (NATA)IBA
01/2022 - 10/2021
2Complement System Proteins (Complement)IBA
01/2021 - 07/2009
2nepafenac (Nevanac)FDA Link
01/2017 - 01/2012
2SuspensionsIBA
01/2017 - 01/2012
2Prednisone (Sone)FDA LinkGeneric
09/2016 - 09/2016
2GlucocorticoidsIBA
09/2016 - 12/2007
2Oxidants (Oxidizing Agents)IBA
07/2009 - 10/2006
2Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
02/2009 - 09/2003
2CytokinesIBA
07/2007 - 03/2003
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2007 - 07/2004
2Messenger RNA (mRNA)IBA
07/2007 - 07/2002
1pegcetacoplanIBA
01/2024
1Angiopoietin-2IBA
12/2023
1faricimabIBA
12/2023
1PlacebosIBA
10/2023
1Anti-Bacterial Agents (Antibiotics)IBA
09/2023
1VancomycinFDA LinkGeneric
09/2023
1Amikacin (A.M.K)FDA LinkGeneric
09/2023
1VS 261IBA
12/2022
1risuteganibIBA
11/2022
1Neurofibromin 2 (Merlin)IBA
01/2022
1Plasma KallikreinIBA
12/2021
1perflutren (octafluoropropane)FDA Link
11/2021
1IntegrinsIBA
09/2021
1sarilumabIBA
09/2021

Therapy/Procedure

23Therapeutics
01/2024 - 03/2003
14Injections
03/2024 - 11/2002
7Vitrectomy
03/2024 - 06/2002
7Intravitreal Injections
09/2023 - 09/2003
7Traction
11/2021 - 01/2004
5Aftercare (After-Treatment)
09/2021 - 09/2009
4Lasers (Laser)
11/2016 - 09/2011
3Light Coagulation
01/2019 - 10/2015
3Cataract Extraction
01/2012 - 07/2005
2Photochemotherapy (Photodynamic Therapy)
07/2017 - 01/2005
2Brachytherapy
08/2013 - 02/2013
2Filtering Surgery
10/2008 - 06/2006
1Dacryocystorhinostomy
09/2023